Franziska Pühringer-Oppermann

The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus

Mario Sarbia, N.L. Ott, Franziska Pühringer-Oppermann et al. · British Journal of Cancer · 2007 · 52 citations · Full text

Medicine, Oncology, Surgery +17

The prognostic significance of genetic polymorphisms (Methylenetetrahydrofolate Reductase C677T, Methionine Synthase A2756G, Thymidilate Synthase tandem repeat polymorphism) in multimodally treated oesophageal squamous cell carcinoma

Mario Sarbia, M. Stahl, Claus von Weyhern et al. · British Journal of Cancer · 2005 · 49 citations · Full text

Medicine, Genetics, Oncology +14

c-myc Amplification Is Frequent in Esophageal Adenocarcinoma and Correlated with the Upregulation of VEGF-A Expression

Burkhard H.A. von Rahden, H. J. Stein, Franziska Pühringer-Oppermann et al. · Neoplasia · 2006 · 39 citations · Full text

Medicine, Molecular Biology, Oncology +17

Lack of EGFR gene mutations in exons 19 and 21 in esophageal (Barrett’s) adenocarcinomas

Franziska Pühringer-Oppermann, H. J. Stein, Mario Sarbia · Diseases of the Esophagus · 2007 · 28 citations · Full text

Medicine, Genetics, Oncology +17

The predictive value of genes of the TGF-β1 pathway in multimodally treated squamous cell carcinoma of the esophagus

Franziska Pühringer-Oppermann, Mario Sarbia, Björn L.D.M. Brücher · International Journal of Colorectal Disease · 2009 · 14 citations

Medicine, Genetics, Oncology +13